ABSTRACT
P214 Table 1Mortality by groups Age groups 30–39 40–49 50–59 60–69 70–79 >80 Mortality (%) 0 40 50 71.4 79.5 100 CFS 1 2 3 4 5 6 Mortality (%) 20 43 79 77.3 87.5 100 Number of comorbidities 0 1 2 3 4 Mortality (%) 42.9 46.1 76.9 80 84.6 Time to admission to RSU (days) Less than 1 1-2 3-7 8 or more Mortality (%) 63.2 64.7 81.5 81.8 ConclusionThese data demonstrate the high mortality in patients with respiratory failure secondary to COVID-19 pneumonitis admitted to our RSU, particularly in those who were not for escalation to ICU. Increasing age, number of comorbidities and CFS were associated with treatment failure as well as time between presentation and admission to RSU. Careful patient selection with consideration of these factors is vital when identifying patients appropriate for respiratory support.